EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Stigmatization and Resources Allocation-Ethical Dilemmas for HIV Positive Intravenous Drug Users

Sarosh Saleem, Maryam Riaz Tarar

Journal of Shalamar Medical & Dental College - JSHMDC · 2019

DOI: 10.53685/jshmdc.v1i2.69 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Shalamar Medical & Dental College - JSHMDC, 2019. Verfasst von Sarosh Saleem und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The burden of disease due to Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Pakistan is on the rise. According to an estimate approximately 0.165 million people in Pakistan are infected with HIV and 17,149 person are currently receiving treatment for HIV/AIDS. The prevalence of HIV is 20% for intravenous Drug Users (IVDUs) while national surveillance data shows rate of infection in most major cities in range of 15-50%. In light of such alarming figures, distribution of resources and stigmatization are two ethical issues that gain attention of not only healthcare providers but also patients. Following is a case with discussion on these ethical issues.

Zitieren

APA

Saleem, S., & Tarar, M. R. (2019). Stigmatization and Resources Allocation-Ethical Dilemmas for HIV Positive Intravenous Drug Users. Journal of Shalamar Medical & Dental College - JSHMDC. https://doi.org/10.53685/jshmdc.v1i2.69

Vancouver

Saleem S, Tarar MR. Stigmatization and Resources Allocation-Ethical Dilemmas for HIV Positive Intravenous Drug Users. Journal of Shalamar Medical & Dental College - JSHMDC. 2019. doi:10.53685/jshmdc.v1i2.69

BibTeX
@article{Saleem2019,
  author = {Saleem, Sarosh and Tarar, Maryam Riaz},
  title = {Stigmatization and Resources Allocation-Ethical Dilemmas for HIV Positive Intravenous Drug Users},
  journal = {Journal of Shalamar Medical & Dental College - JSHMDC},
  year = {2019},
  doi = {10.53685/jshmdc.v1i2.69}
}
Kostenlos starten →